HBOX Therapies develops therapies based on the principle of minimally invasive targeted hyperoxygenation.
hbox's investors include HTGF (High-Tech Gruenderfonds), TechVision Fund, EIC Accelerator, Dr. Peter Borges.
hbox is headquartered in Aachen, Germany.
HBOX Therapies develops therapies based on the principle of minimally invasive targeted hyperoxygenation.
hbox is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"hbox — Funding & Investors." VCBacked, October 30, 2023, https://www.vcbacked.co/company/hbox. Accessed October 1, 2026.
VCBacked. (2023). hbox — Funding & Investors. Retrieved October 1, 2026, from https://www.vcbacked.co/company/hbox
{{cite web |title=hbox — Funding & Investors |url=https://www.vcbacked.co/company/hbox |website=VCBacked |access-date=October 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated